Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | APLNR | P35414 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | GRM4 | Q14833 | 4/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | GRM8 | O00222 | 1/20 | 0.31 |
| ▸ | GRM6 | O15303 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13225976 | 1.00 | GAA (0.50) | GAAL3MBTL1APLNRSLC6A4SLC1A2 | |
| SCHEMBL4397787 | 1.00 | GAA (0.50) | GAAL3MBTL1APLNRSLC6A4SLC1A2 | |
| SCHEMBL9715915 | 0.83 | GAA (0.50) | GAAL3MBTL1ALDH1A1KDM4EALOX15 | |
| SCHEMBL23616413 | 0.83 | GAA (0.40) | GAAL3MBTL1APLNRSLC6A4SLC1A2 | |
| SCHEMBL1933219 | 0.81 | GAA (0.48) | GAAL3MBTL1ALDH1A1KDM4EALOX15 | |
| SCHEMBL13225973 | 0.81 | GAA (0.48) | GAAL3MBTL1ALDH1A1KDM4EALOX15 | |
| SCHEMBL13225974 | 0.81 | GAA (0.48) | GAAL3MBTL1ALDH1A1KDM4EALOX15 | |
| SCHEMBL8599636 | 0.81 | GAA (0.48) | GAAL3MBTL1ALDH1A1KDM4EALOX15 | |
| SCHEMBL1231230 | 0.79 | GAA (0.47) | GAAL3MBTL1ALDH1A1KDM4EALOX15 | |
| SCHEMBL438904 | 0.79 | SLC1A2 (0.42) | GAAL3MBTL1APLNRSLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 578 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4714957-A1 | (METH)ACRYLATE COMPOUND PRODUCTION METHOD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-03-25 | — | — | EP | claimed |
| US-20250298040-A1 | MEASUREMENT OF REACTIVE OXYGEN SPECIES TO ASSESS RED BLOOD CELL QUALITY | UNIVERSITY OF MARYLAND, BALTIMORE | 2025-09-25 | — | — | US | claimed |
| WO-2024237180-A1 | (METH)ACRYLATE COMPOUND PRODUCTION METHOD | 三菱瓦斯化学株式会社 | 2024-11-21 | — | — | WO | claimed |
| EP-4244285-A1 | PROCESSING OF POLYETHYLENE-BASED COMPOSITIONS AND PRODUCTS THEREFROM | Braskem, S.A. (BR) | 2023-09-20 | — | — | EP | claimed |
| EP-4244264-A1 | PROCESSING OF POLYPROPYLENE AND PRODUCTS THEREFROM | Braskem, S.A. (BR) | 2023-09-20 | — | — | EP | claimed |
| CN-113185724-B | All-rubber-powder elastomer material capable of being repeatedly processed and preparation method thereof | 华南理工大学 | 2022-12-16 | — | — | CN | claimed |
| US-20220387407-A1 | COMPOSITIONS AND METHODS FOR ATTENUATING OPIOID INDUCED CARDIO AND/OR RESPIRATORY DEPRESSION | UNIV CASE WESTERN RESERVE (US) | 2022-12-08 | — | — | US | claimed |
| WO-2022251679-A1 | NITROXIDE RADICALS FOR USE AS ANTIVIRAL TREATMENT FOR CORONAVIRUS INFECTION | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-12-01 | — | — | WO | claimed |
| US-20220273678-A1 | Compositions and Methods for Inhibiting and Treating Coronavirus Infections | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-09-01 | — | — | US | claimed |
| US-20220153883-A1 | PROCESSING OF POLYETHYLENE-BASED COMPOSITIONS AND PRODUCTS THEREFROM | BRASKEM S.A. (BR) | 2022-05-19 | — | — | US | claimed |
| WO-1999011674-A1 | METHOD FOR PRODUCING PARTICULATE POLYMERS BY ADDITIONALLY USING A STABLE N-OXYL RADICAL | BASF AKTIENGESELLSCHAFT (DE) | 1999-03-11 | — | — | WO | claimed |
| WO-1999000427-A1 | METHOD FOR AQUEOUS EMULSION POLYMERIZATION INITIATED BY FREE-RADICALS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-07 | — | — | WO | claimed |
| WO-1998055684-A1 | MULTI-COMPONENT SYSTEM FOR MODIFYING, DECOMPOSING OR BLEACHING LIGNIN, MATERIALS CONTAINING LIGNIN OR SIMILAR SUBSTANCES AND METHODS FOR PRODUCING THE SAME | Consortium für elektrochemische Industrie GmbH (DE) | 1998-12-10 | — | — | WO | claimed |
| WO-1998051772-A1 | ENZYMATIC BLEACHING SYSTEM CONTAINING NEW COMPOUNDS FOR INTENSIFYING ENZYMATIC ACTION | CALL, KRIMHILD (DE) | 1998-11-19 | — | — | WO | claimed |
| US-5773635-A | ALDOL CONDENSATION; IN PRESENCE OF OXYGEN OR NITRIC OXIDE | BASF AKTIENGESELLSCHAFT (DE) | 1998-06-30 | — | — | US | claimed |
| EP-0822835-A1 | HYBRID MAGNETIC RESONANCE CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-02-11 | — | — | EP | claimed |
| EP-0691329-B1 | Process for the preparation of polyencarbonyl compounds with high content of the all E-isomer and their acetals or ketales | BASF AG (DE) | 1997-10-29 | — | — | EP | claimed |
| WO-1996032967-A1 | HYBRID MAGNETIC RESONANCE CONTRAST AGENTS | IMARX PHARMACEUTICAL CORPORATION (US) | 1996-10-24 | — | — | WO | claimed |
| EP-0691329-A1 | Process for the preparation of polyencarbonyl compounds with high content of the all E-isomer and their acetals or ketales | BASF AKTIENGESELLSCHAFT (DE) | 1996-01-10 | — | — | EP | claimed |
| US-5407657-A | Containing a metal chelate and a free radical nitroxide | IMARX THERAPEUTICS, INC. | 1995-04-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220273678-A1 | Compositions and Methods for Inhibiting and Treating Coronavirus Infections | ACE2, SARS1, ACE | GAA 1435/4885L3MBTL1 967/4885APLNR 3558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.